Cellular and Molecular Basis of Pulmonary Arterial Hypertension

This publication has 131 references indexed in Scilit:

• Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue
  Human Molecular Genetics, 2008
• Functional Characterization of Bone Morphogenetic Protein Binding Sites and Smad1/5 Activation in Human Vascular Cells
  Molecular Pharmacology, 2008
• Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension
  American Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
• The role of CXC chemokines in pulmonary fibrosis
  Journal of Clinical Investigation, 2007
• Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle‐like cells regulated by myocardin involved in hypoxia‐induced pulmonary vascular remodelling
  International Journal of Experimental Pathology, 2006
• Serotonin Increases Susceptibility to Pulmonary Hypertension in BMPR2 -Deficient Mice
  Circulation Research, 2006
• Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension
  American Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
• Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension
  The FASEB Journal, 2004
• Molecular regulation of vessel maturation
  Nature Medicine, 2003
• Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein–Induced Activation of Endothelial Cells
  Circulation, 2002